Biomx Ltd (PHGE) Stock Price, Quote & News

Company Profile

BiomX Inc., a holding company, focuses on defense, security, and critical infrastructure technologies. The company's portfolio targets various niches, such as counter-drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting. It serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers. The company was founded in 2015 and is based in Dover, Delaware.

Industry: Aerospace & Defense

Sector: Industrials

Website: www.biomx.com

Address:

850 New Burton Road, Suite 201, Dover, United States

laurenlee Aug. 4 at 4:53 PM

$PHGE

0 · Reply

laurenlee Aug. 4 at 4:52 PM

$PHGE

0 · Reply

kamenrider888 Aug. 4 at 4:37 PM

$PHGE lmao...as said months ago...this is a scam stock pushed by boiler room bots ..from $6 to $0.17 😂

0 · Reply

wowwwwww2 Aug. 4 at 3:30 PM

$PHGE smh

0 · Reply

laurenlee Aug. 4 at 2:43 PM

$PHGE t3 partnership and backing

0 · Reply

TraderBuckNKY Aug. 4 at 2:38 PM

$PHGE perhaps they made their allowance money for the week on last nights pump and dump and we won't see another for a week or two...

0 · Reply

Lyn30 Aug. 4 at 2:25 PM

$PHGE CTB 750% Float 8.07M

1 · Reply

laurenlee Aug. 4 at 2:03 PM

$PHGE has a strong big brother

0 · Reply

KoalaFlipper Aug. 4 at 1:56 PM

$PHGE 🚀📈

0 · Reply

Lyn30 Aug. 4 at 1:56 PM

$PHGE Last pump was .37 to 1.62 Food for thought

0 · Reply

BiomX And Water.IO Agree To Updated Zorronet Acquisition Terms

Jul 24, 2026, 7:45 AM EDT - 11 days ago

BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe

Jul 17, 2026, 8:00 AM EDT - 18 days ago

BiomX Proxy statement: Proxy filing

Jul 10, 2026, 7:25 AM EDT - 25 days ago

BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities

Jul 8, 2026, 7:05 AM EDT - 27 days ago

BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities

Jul 6, 2026, 8:32 AM EDT - 4 weeks ago

BiomX: Subsidiary Zorronet Commences Installation and Operation of AI-Powered Detection Systems Under Israel Railways Agreement

2026-06-29T21:15:26.000Z - 5 weeks ago

BiomX files to sell 7.16M shares of common stock for holders

Jun 29, 2026, 8:00 AM EDT - 5 weeks ago

BiomX Registration statement: Registration filing

Jun 24, 2026, 8:38 AM EDT - 5 weeks ago

BiomX: Next-Gen Counter Drone Solutions will be Showcased by DFSL at ISC 2026

Jun 22, 2026, 8:00 AM EDT - 6 weeks ago

BiomX Proxy statement: Proxy filing

Jun 18, 2026, 9:15 AM EDT - 6 weeks ago

BiomX Provides Update on Defense Technology Portfolio and Growth Strategy

Jun 15, 2026, 7:00 AM EDT - 7 weeks ago

BiomX Slides: Investor presentation

2026-06-12T13:16:16.000Z - 7 weeks ago

BiomX announces acceptance of plan to regain compliance with NYSE

Jun 12, 2026, 9:00 AM EDT - 7 weeks ago

BiomX Announces NYSE American Acceptance of Plan to Regain Compliance

Jun 11, 2026, 9:03 AM EDT - 7 weeks ago

BiomX: Zorronet's AI Security Experts Provide In-Depth Review on Why Security AI Must Move Beyond Detection to Understanding in High-Stakes Global Events

Jun 8, 2026, 8:00 AM EDT - 2 months ago

BiomX Proxy statement: Proxy filing

2026-06-02T13:56:30.000Z - 2 months ago

BiomX appoints Gabby Sarusi as strategic advisor

Jun 2, 2026, 9:32 AM EDT - 2 months ago

Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit

Jun 1, 2026, 9:25 AM EDT - 2 months ago

Zorronet Brings Autonomous C5ISR to Hardened Sites Without Public Cloud Dependence

2026-05-27T15:22:44.000Z - 2 months ago

BiomX names Roy Timor-Rousso as Chief Business Officer

May 27, 2026, 9:40 AM EDT - 2 months ago

BiomX Appoints IDF Colonel (res.) Roy Timor-Rousso as Chief Business Officer to Strengthen Defense & Security Operations

May 20, 2026, 4:00 PM EDT - 2 months ago

BiomX Quarterly report: Q1 2026

May 6, 2026, 4:15 PM EDT - 3 months ago

BiomX's Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand

Apr 16, 2026, 4:30 PM EDT - 3 months ago

Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems

Apr 13, 2026, 9:20 AM EDT - 4 months ago

BiomX Accelerates Defense Technology Buildout with DFSL Acquisition

Apr 10, 2026, 8:30 AM EDT - 4 months ago

BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications

2026-04-09T18:36:16.000Z - 4 months ago

Biomx Inc trading halted, news pending

2026-04-01T14:10:15.000Z - 4 months ago

Biomx Inc trading resumes

2026-04-01T13:38:15.000Z - 4 months ago

Biomx Inc trading halted, news pending

Mar 31, 2026, 10:48 AM EDT - 4 months ago

BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone System

Mar 30, 2026, 9:28 AM EDT - 4 months ago

BiomX Adds Former Mossad Deputy to Advisory Board

2026-03-27T20:40:15.000Z - 4 months ago

BiomX receives noncompliance notification from Nasdaq

Mar 27, 2026, 4:30 PM EDT - 4 months ago

BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency

2026-03-26T13:08:14.000Z - 4 months ago

BiomX launches X Security & Defense subsidiary in Israel

Mar 26, 2026, 8:48 AM EDT - 4 months ago

BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations

Mar 25, 2026, 8:00 AM EDT - 4 months ago

BiomX Proxy statement: Proxy filing

2026-03-19T13:20:44.000Z - 4 months ago

BiomX issues letter to shareholders

Mar 19, 2026, 9:15 AM EDT - 4 months ago

BiomX CEO Issues Letter to Stockholders

Mar 11, 2026, 8:00 AM EDT - 5 months ago

BiomX Transcript: EGM 2026

2026-03-09T14:55:29.000Z - 5 months ago

BiomX downgraded to Neutral from Buy at H.C. Wainwright

2026-03-09T13:07:20.000Z - 5 months ago

BiomX names Michael Oster as CEO, David Rokach as CFO

Mar 9, 2026, 9:00 AM EDT - 5 months ago

BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of Growth

2026-03-05T16:00:36.000Z - 5 months ago

Biomx Inc trading resumes

2026-03-05T15:55:32.000Z - 5 months ago

Biomx Inc trading halted, volatility trading pause

Feb 25, 2026, 8:00 AM EST - 5 months ago

BiomX Transcript: EGM 2026

Feb 19, 2026, 7:00 AM EST - 5 months ago

BiomX Annual report: Q4 2025

Feb 13, 2026, 7:00 AM EST - 6 months ago

BiomX Proxy statement: Proxy Filing

2026-02-09T21:40:33.000Z - 6 months ago

BiomX files to sell 5.31M shares of common stock for holders

Feb 9, 2026, 7:00 AM EST - 6 months ago

BiomX Registration statement: Registration Filing

Feb 3, 2026, 7:00 AM EST - 6 months ago

BiomX Proxy statement: Proxy Filing

2026-01-29T14:50:55.000Z - 6 months ago

Biomx Inc trading resumes

2026-01-29T14:46:29.000Z - 6 months ago

Biomx Inc trading halted, volatility trading pause

Jan 27, 2026, 1:41 PM EST - 6 months ago

BiomX Issues Statement Regarding Recent Common Stock Trading Activity

2025-12-29T13:15:13.000Z - 7 months ago

BiomX announces $3M private placement

Dec 29, 2025, 8:00 AM EST - 7 months ago

BiomX Announces $3.0 Million Private Placement

Nov 25, 2025, 4:40 PM EST - 8 months ago

BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis

Nov 12, 2025, 8:30 AM EST - 9 months ago

BiomX Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:30 AM EST - 9 months ago

BiomX Quarterly report: Q3 2025

Nov 12, 2025, 8:30 AM EST - 9 months ago

BiomX Earnings release: Q3 2025

Nov 12, 2025, 7:30 AM EST - 9 months ago

BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates

Oct 17, 2025, 8:30 AM EDT - 10 months ago

BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways

Aug 28, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

Aug 28, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

Aug 19, 2025, 8:19 AM EDT - 1 year ago

BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis

Aug 15, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

Aug 13, 2025, 8:00 AM EDT - 1 year ago

BiomX Earnings Call Transcript: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 1 year ago

BiomX Quarterly report: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 1 year ago

BiomX Earnings release: Q2 2025

Aug 13, 2025, 6:30 AM EDT - 1 year ago

BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates

Aug 6, 2025, 8:30 AM EDT - 1 year ago

BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025

Jul 14, 2025, 9:00 AM EDT - 1 year ago

BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis

Jul 8, 2025, 8:30 AM EDT - 1 year ago

BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis

May 19, 2025, 10:02 AM EDT - 1 year ago

BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference

May 15, 2025, 2:00 PM EDT - 1 year ago

BiomX Earnings Call Transcript: Q1 2025

May 15, 2025, 2:00 PM EDT - 1 year ago

BiomX Quarterly report: Q1 2025

May 15, 2025, 2:00 PM EDT - 1 year ago

BiomX Earnings release: Q1 2025

May 15, 2025, 6:30 AM EDT - 1 year ago

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates

May 8, 2025, 7:00 AM EDT - 1 year ago

BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025

Apr 17, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

BiomX Registration statement: Registration Filing

Apr 3, 2025, 11:00 AM EDT - 1 year ago

BiomX Transcript: KOL Event

Apr 1, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

Apr 1, 2025, 6:30 AM EDT - 1 year ago

BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure

Mar 31, 2025, 9:00 AM EDT - 1 year ago

BiomX Earnings Call Transcript: Q4 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

BiomX Annual report: Q4 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

BiomX Earnings release: Q4 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

BiomX Slides: Q4 2024

Mar 31, 2025, 6:30 AM EDT - 1 year ago

BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)

Mar 27, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

Mar 25, 2025, 6:30 AM EDT - 1 year ago

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates

Mar 19, 2025, 12:35 PM EDT - 1 year ago

BiomX to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Mar 17, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

Nov 14, 2024, 8:00 AM EST - 1 year ago

BiomX Earnings Call Transcript: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

BiomX Quarterly report: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

BiomX Earnings release: Q3 2024

Nov 14, 2024, 6:30 AM EST - 1 year ago

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates

Nov 12, 2024, 12:20 PM EST - 1 year ago

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024

Oct 15, 2024, 7:00 AM EDT - 1 year ago

BiomX Announces a Mandatory Unit Separation

Sep 18, 2024, 8:00 AM EDT - 2 years ago

BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference

Sep 9, 2024, 7:00 AM EDT - 2 years ago

BiomX Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 4, 2024, 8:00 AM EDT - 2 years ago

BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 16, 2024, 10:55 AM EDT - 2 years ago

UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split

Aug 15, 2024, 8:00 AM EDT - 2 years ago

BiomX Earnings Call Transcript: Q2 2024

Aug 15, 2024, 8:00 AM EDT - 2 years ago

BiomX Quarterly report: Q2 2024

Aug 15, 2024, 8:00 AM EDT - 2 years ago

BiomX Earnings release: Q2 2024

Aug 15, 2024, 6:30 AM EDT - 2 years ago

BiomX Inc. Announces 1-for-10 Reverse Stock Split

Aug 15, 2024, 6:30 AM EDT - 2 years ago

BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates

Aug 8, 2024, 7:00 AM EDT - 2 years ago

BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024

Jul 29, 2024, 7:00 AM EDT - 2 years ago

BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance

Jul 11, 2024, 8:00 AM EDT - 2 years ago

BiomX Registration statement: Registration Filing

Jul 10, 2024, 6:30 AM EDT - 2 years ago

BiomX Inc. Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common Stock

laurenlee Aug. 4 at 4:53 PM

$PHGE

0 · Reply

laurenlee Aug. 4 at 4:52 PM

$PHGE

0 · Reply

kamenrider888 Aug. 4 at 4:37 PM

$PHGE lmao...as said months ago...this is a scam stock pushed by boiler room bots ..from $6 to $0.17 😂

0 · Reply

wowwwwww2 Aug. 4 at 3:30 PM

$PHGE smh

0 · Reply

laurenlee Aug. 4 at 2:43 PM

$PHGE t3 partnership and backing

0 · Reply

TraderBuckNKY Aug. 4 at 2:38 PM

$PHGE perhaps they made their allowance money for the week on last nights pump and dump and we won't see another for a week or two...

0 · Reply

Lyn30 Aug. 4 at 2:25 PM

$PHGE CTB 750% Float 8.07M

1 · Reply

laurenlee Aug. 4 at 2:03 PM

$PHGE has a strong big brother

0 · Reply

KoalaFlipper Aug. 4 at 1:56 PM

$PHGE 🚀📈

0 · Reply

Lyn30 Aug. 4 at 1:56 PM

$PHGE Last pump was .37 to 1.62 Food for thought

0 · Reply

laurenlee Aug. 4 at 1:44 PM

$PHGE needs contract news love bis big brother this will grow nice to be in early

0 · Reply

laurenlee Aug. 4 at 1:30 PM

$PHGE

0 · Reply

ramos4444 Aug. 4 at 1:14 PM

$PHGE Long live the new king🦁👑🚀 💸💸💸💸💸💸💸💸💸💸💸💸💸💸💸

0 · Reply

SlutGopher Aug. 4 at 12:54 PM

$PHGE let it touch low .16s before entry

0 · Reply

Gmoney2020 Aug. 4 at 12:51 PM

$PHGE no volume

0 · Reply

BullishAnt Aug. 4 at 12:00 PM

$PHGE switched to $IPW it stole my money yesterday and today it will make it back

0 · Reply

SlutGopher Aug. 4 at 12:00 PM

$PHGE Shorts do your best please

0 · Reply

SlutGopher Aug. 4 at 11:59 AM

$PHGE 23% short interest ehh

0 · Reply

BullishAnt Aug. 4 at 11:53 AM

$PHGE did I get scammed?

0 · Reply

taneraydar Aug. 4 at 11:46 AM

$PHGE getting ugly again

0 · Reply

SlutGopher Aug. 4 at 11:26 AM

$PHGE Nawl nuh nawl nawl nawl🤠

0 · Reply

WSF69 Aug. 4 at 11:24 AM

$PHGE stfu

0 · Reply

Market Cap	2.17M
Revenue (ttm)	0.00
Net Income (ttm)	-36.20M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	2,023,555
Avg Vol	5,529,018
Day's Range	N/A - N/A
Shares Out	11.80M
Stochastic %K	43%
Beta	1.30
Analysts	Hold
Price Target	$26.00